An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Investigational Treatment Gaining Popularity Online
The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning properties. Viewers are urged to message these accounts directly for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of uncertain source.
Some professionals stated the popularity for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.
Service Reaction and Material Elimination
Based on TikTok, the service has taken down violative content and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the service secure and investing in enhancing compliance measures.
Online Trading Activities
Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays groups with numerous of users, filled with photos of weight loss, positive testimonials and detailed instructions for preparing or administering at residence.
Within minutes of entering one community, a vendor posted WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.
Product Information and Costs
Inside these groups, messages display black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When asked how much time a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service said it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is sound, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has already seen patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational substance not yet approved … may expose patients to possibly serious health risks”.
